LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
92.07
-2.47 (-2.61%)
At close: Nov 19, 2026, 4:00 PM EST
92.07
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:27 PM EST
LivaNova Revenue
LivaNova had revenue of $393.15M in the quarter ending September 30, 2026, with 9.89% growth. This brings the company's total for the last twelve months to $1.51B, up 11.71% year-over-year. In the year 2025, LivaNova had annual revenue of $1.39B with 10.74% growth. That makes LivaNova the 5,987th largest company in the world by revenue and 1,505th in the United States.
Revenue (ttm)
$1.51B
Revenue Growth
+11.71%
P/S Ratio
3.37
Revenue / Employee
$456,641
Employees
3,300
Market Cap
5.07B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full LivaNova breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 134.62M | 10.74% |
| Dec 31, 2024 | 1.25B | 99.89M | 8.66% |
| Dec 31, 2023 | 1.15B | 131.74M | 12.89% |
| Dec 31, 2022 | 1.02B | -13.56M | -1.31% |
| Dec 31, 2021 | 1.04B | 101.12M | 10.82% |
| Dec 31, 2020 | 934.24M | -149.93M | -13.83% |
| Dec 31, 2019 | 1.08B | -22.79M | -2.06% |
| Dec 31, 2018 | 1.11B | 94.68M | 9.35% |
| Dec 31, 2017 | 1.01B | 47.42M | 4.91% |
| Dec 31, 2016 | 964.86M | 673.30M | 230.93% |
| Apr 24, 2015 | 291.56M | 9.54M | 3.38% |
| Apr 25, 2014 | 282.01M | 27.69M | 10.89% |
| Apr 26, 2013 | 254.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bruker | 3.51B |
| Insulet | 3.19B |
| Globus Medical | 3.14B |
| Bio-Rad Laboratories | 2.59B |
| Bio-Rad Laboratories | 2.59B |
| Haemonetics | 1.38B |
| Neogen | 884.00M |
| iRhythm Holdings | 854.04M |
LIVN News
- 2 days ago - LivaNova Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - LivaNova Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 9 days ago - LivaNova Transcript: 8th Annual Wolfe Research Healthcare Conference - Transcripts
- 10 days ago - LivaNova Transcript: UBS Global Healthcare Conference - Transcripts
- 10 days ago - LivaNova price target raised to $120 from $105 at Barclays - TheFly
- 14 days ago - LivaNova price target raised to $115 from $95 at Mizuho - TheFly
- 14 days ago - LivaNova price target raised to $111 from $95 at Baird - TheFly
- 15 days ago - LivaNova price target raised to $120 from $100 at Jefferies - TheFly